Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
NCT00321412
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
191
Enrollment
INDUSTRY
Sponsor class
Conditions
Inflammatory Bowel Disease
Intestinal Fistula
Interventions
DRUG:
AST-120
Sponsor
Ocera Therapeutics